Clinical Neurochemistry Laboratory,
Institute of Neuroscience and Physiology,
Department of Psychiatry and Neurochemistry,
The Sahlgrenska Academy,
Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy
Henrik Zetterberg has not added Biography.
If you are Henrik Zetterberg and would like to personalize this page please email our Author Liaison for assistance.
Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease.
Molecular neurodegeneration Jan, 2010 | Pubmed ID: 20145736
Association of APOE with age at onset of sporadic amyotrophic lateral sclerosis.
Journal of the neurological sciences Oct, 2008 | Pubmed ID: 18656208
Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
Neuroscience letters Feb, 2009 | Pubmed ID: 19022350
Synaptic retrogenesis and amyloid-beta in Alzheimer's disease.
Journal of Alzheimer's disease : JAD , 2009 | Pubmed ID: 19158416
The szilard hypothesis on the nature of aging revisited.
Genetics May, 2009 | Pubmed ID: 19403867
[Biomarkers in cerebrospinal fluid and blood in memory complaints].
Lakartidningen May 13-19, 2009 | Pubmed ID: 19585836
Future screening for incipient Alzheimer's disease--the influence of prevalence on test performance.
European neurology , 2009 | Pubmed ID: 19602894
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.
JAMA Jul, 2009 | Pubmed ID: 19622817
Sustained release of neuron-specific enolase to serum in amateur boxers.
Brain injury Aug, 2009 | Pubmed ID: 19636997
Amyloid beta and APP as biomarkers for Alzheimer's disease.
Experimental gerontology Jan, 2010 | Pubmed ID: 19698775
Biological markers of amyloid beta-related mechanisms in Alzheimer's disease.
Experimental neurology Jun, 2010 | Pubmed ID: 19815015
Total and phosphorylated tau protein as biological markers of Alzheimer's disease.
Experimental gerontology Jan, 2010 | Pubmed ID: 19853650
Subcortical vascular dementia biomarker pattern in mild cognitive impairment.
Dementia and geriatric cognitive disorders , 2009 | Pubmed ID: 19864909
CSF biomarkers: pinpointing Alzheimer pathogenesis.
Annals of the New York Academy of Sciences Oct, 2009 | Pubmed ID: 19906258
Kinesin light chain 1 gene haplotypes in three conformational diseases.
Neuromolecular medicine Sep, 2010 | Pubmed ID: 19911314
Converging molecular pathways in human neural development and degeneration.
Neuroscience research Mar, 2010 | Pubmed ID: 19961883
Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract.
Mechanisms of ageing and development Feb, 2010 | Pubmed ID: 20064547
Is there a CSF biomarker profile related to depression in elderly women?
Psychiatry research Apr, 2010 | Pubmed ID: 20132991
Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.
BMC medical genetics Mar, 2010 | Pubmed ID: 20196834
Biochemical markers in Alzheimer's disease clinical trials.
Biomarkers in medicine Feb, 2010 | Pubmed ID: 20387305
Is it time for biomarker-based diagnostic criteria for prodromal Alzheimer's disease?
Alzheimer's research & therapy Apr, 2010 | Pubmed ID: 20441609
Study bridges the gap between advanced mass spectrometry and immuno-based multiplex assays.
Biomarkers in medicine Jun, 2008 | Pubmed ID: 20477410
Acute effect on the Aβ isoform pattern in CSF in response to γ-secretase modulator and inhibitor treatment in dogs.
Journal of Alzheimer's disease : JAD , 2010 | Pubmed ID: 20634579
Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid.
Cerebrospinal fluid research Jul, 2010 | Pubmed ID: 20673341
Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people.
Archives of neurology Aug, 2010 | Pubmed ID: 20697045
Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease.
International journal of Alzheimer's disease Jul, 2010 | Pubmed ID: 20721354
To know or not to know: ethical issues related to early diagnosis of Alzheimer's disease.
International journal of Alzheimer's disease Jun, 2010 | Pubmed ID: 20798843
Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid.
International journal of Alzheimer's disease Jul, 2010 | Pubmed ID: 20798852
Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease.
Brain research Nov, 2010 | Pubmed ID: 20875798
Use of theragnostic markers to select drugs for phase II/III trials for Alzheimer disease.
Alzheimer's research & therapy Nov, 2010 | Pubmed ID: 21122172
Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-β is an early biomarker for mild cognitive impairment preceding Alzheimer's disease.
Journal of Alzheimer's disease : JAD , 2011 | Pubmed ID: 21157031
Cerebrospinal fluid analysis should be considered in patients with cognitive problems.
International journal of Alzheimer's disease Jul, 2010 | Pubmed ID: 21487447
Biomarker-based dissection of neurodegenerative diseases.
Progress in neurobiology Dec, 2011 | Pubmed ID: 21524681
Identification of novel α-synuclein isoforms in human brain tissue by using an online nanoLC-ESI-FTICR-MS method.
Neurochemical research Nov, 2011 | Pubmed ID: 21674238
Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer's disease.
Journal of Alzheimer's disease : JAD , 2011 | Pubmed ID: 21860087
Biomarkers for microglial activation in Alzheimer's disease.
International journal of Alzheimer's disease , 2011 | Pubmed ID: 22114747
Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid β levels in humans.
PloS one , 2011 | Pubmed ID: 22194817
CSF-biomarkers in Olympic boxing: diagnosis and effects of repetitive head trauma.
PloS one , 2012 | Pubmed ID: 22496755
An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid β and amyloid precursor protein in human and cat cerebrospinal fluid.
Journal of mass spectrometry : JMS May, 2012 | Pubmed ID: 22576872
CSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease.
PloS one , 2012 | Pubmed ID: 22701578
Cerebrospinal fluid biomarkers for Alzheimer's disease: more to come?
Journal of Alzheimer's disease : JAD , 2013 | Pubmed ID: 22710917
Peptidome analysis of cerebrospinal fluid by LC-MALDI MS.
PloS one , 2012 | Pubmed ID: 22880031
Proficiency testing programs for Alzheimer's disease cerebrospinal fluid biomarkers.
Biomarkers in medicine Aug, 2012 | Pubmed ID: 22917142
Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.
Biomarkers in medicine Aug, 2012 | Pubmed ID: 22917143
Low cerebrospinal fluid sulfatide predicts progression of white matter lesions: The LADIS study.
Dementia and geriatric cognitive disorders , 2012 | Pubmed ID: 22922641
Fluid biomarkers in Alzheimer disease.
Cold Spring Harbor perspectives in medicine Sep, 2012 | Pubmed ID: 22951438
Serum levels of LIGHT in MS.
Multiple sclerosis (Houndmills, Basingstoke, England) Jun, 2013 | Pubmed ID: 23037546
The neuropathology and neurobiology of traumatic brain injury.
Neuron Dec, 2012 | Pubmed ID: 23217738
Superoxide dismutase gene polymorphisms in patients with age-related cataract.
Ophthalmic genetics Sep, 2013 | Pubmed ID: 23289810
Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease.
Brain research Jun, 2013 | Pubmed ID: 23541617
Genetic variation of superoxide dismutases in patients with primary open-angle glaucoma.
Ophthalmic genetics Jun, 2014 | Pubmed ID: 23638916
The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer disease.
The Medical clinics of North America May, 2013 | Pubmed ID: 23642576
Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease.
PloS one , 2013 | Pubmed ID: 23799095
Cerebrospinal fluid biomarkers in cardiac arrest survivors.
Resuscitation Feb, 2014 | Pubmed ID: 24231570
Increased CSF levels of phosphorylated neurofilament heavy protein following bout in amateur boxers.
PloS one , 2013 | Pubmed ID: 24260563
Automated cerebrospinal fluid cell count--new reference ranges and evaluation of its clinical use in central nervous system infections.
Clinical biochemistry Jan, 2014 | Pubmed ID: 24275252
Cerebrospinal fluid α-synuclein levels in Parkinson's disease--changed or unchanged?
European journal of neurology Mar, 2014 | Pubmed ID: 24330157
Acute sleep deprivation increases serum levels of neuron-specific enolase (NSE) and S100 calcium binding protein B (S-100B) in healthy young men.
Sleep Jan, 2014 | Pubmed ID: 24470708
EPHA2 Polymorphisms in Estonian Patients with Age-Related Cataract.
Ophthalmic genetics , 2016 | Pubmed ID: 24673449
Modulation of β-amyloid by a single dose of GSK933776 in patients with mild Alzheimer's disease: a phase I study.
Alzheimer's research & therapy , 2014 | Pubmed ID: 24716469
The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?
Alzheimer's & dementia : the journal of the Alzheimer's Association Nov, 2014 | Pubmed ID: 24721526
CSF Aβ42 predicts early-onset dementia in Parkinson disease.
Neurology May, 2014 | Pubmed ID: 24748671
Higher CSF interleukin-6 and CSF interleukin-8 in current depression in older women. Results from a population-based sample.
Brain, behavior, and immunity Oct, 2014 | Pubmed ID: 24858658
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease.
Alzheimer's research & therapy , 2014 | Pubmed ID: 24987465
Tau, s-100 calcium-binding protein B, and neuron-specific enolase as biomarkers of concussion-reply.
JAMA neurology Jul, 2014 | Pubmed ID: 25023557
Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function.
Journal of Alzheimer's disease : JAD , 2015 | Pubmed ID: 25420549
An integrated workflow for multiplex CSF proteomics and peptidomics-identification of candidate cerebrospinal fluid biomarkers of Alzheimer's disease.
Journal of proteome research Feb, 2015 | Pubmed ID: 25490617
Cerebrovascular Biomarker Profile Is Related to White Matter Disease and Ventricular Dilation in a LADIS Substudy.
Dementia and geriatric cognitive disorders extra Sep, 2014 | Pubmed ID: 25493088
Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson's disease - a multicenter study.
BMC medical genetics , 2014 | Pubmed ID: 25496089
Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases.
Nature reviews. Neurology Jan, 2015 | Pubmed ID: 25511894
Rarity of the Alzheimer disease-protective APP A673T variant in the United States.
JAMA neurology Feb, 2015 | Pubmed ID: 25531812
Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association Oct, 2015 | Pubmed ID: 25533203
Comment on "An antidepressant decreases CSF Aβ production in healthy individuals and in transgenic AD mice".
Science translational medicine Dec, 2014 | Pubmed ID: 25540322
Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
Brain : a journal of neurology Mar, 2015 | Pubmed ID: 25541191
Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection.
PloS one , 2014 | Pubmed ID: 25541953
Human cerebrospinal fluid increases the excitability of pyramidal neurons in the in vitro brain slice.
The Journal of physiology Jan, 2015 | Pubmed ID: 25556798
Cerebrospinal fluid total prion protein: a potential in vivo marker of cerebral prion pathology.
JAMA neurology Mar, 2015 | Pubmed ID: 25559657
Laboratory testing for lyme neuroborreliosis.
JAMA neurology Jan, 2015 | Pubmed ID: 25581864
Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry.
Neuro-degenerative diseases , 2015 | Pubmed ID: 25591542
The distribution of apolipoprotein E genotype over the adult lifespan and in relation to country of birth.
American journal of epidemiology Feb, 2015 | Pubmed ID: 25609095
A study on the specificity of the association between hippocampal volume and delayed primacy performance in cognitively intact elderly individuals.
Neuropsychologia Mar, 2015 | Pubmed ID: 25613646
Explorative and targeted neuroproteomics in Alzheimer's disease.
Biochimica et biophysica acta Jul, 2015 | Pubmed ID: 25619854
Serum Tau Fragments Predict Return to Play in Concussed Professional Ice Hockey Players.
Journal of neurotrauma May, 2016 | Pubmed ID: 25621407
Estrogen-related Polymorphisms in Estonian Patients with Age-related Cataract.
Ophthalmic genetics Jun, 2015 | Pubmed ID: 25626180
Repetitive concussions--How dangerous are they?
Molecular and cellular neurosciences May, 2015 | Pubmed ID: 25655012
Fluid markers of traumatic brain injury.
Molecular and cellular neurosciences May, 2015 | Pubmed ID: 25659491
Genetic Variants and Related Biomarkers in Sporadic Alzheimer's Disease.
Current genetic medicine reports , 2015 | Pubmed ID: 25664224
Alzheimer's disease--Recent biomarker developments in relation to updated diagnostic criteria.
Clinica chimica acta; international journal of clinical chemistry Sep, 2015 | Pubmed ID: 25668231
A 9-year prospective population-based study on the association between the APOE*E4 allele and late-life depression in Sweden.
Biological psychiatry Nov, 2015 | Pubmed ID: 25708227
Amyloid-β and Tau Dynamics in Human Brain Interstitial Fluid in Patients with Suspected Normal Pressure Hydrocephalus.
Journal of Alzheimer's disease : JAD , 2015 | Pubmed ID: 25720406
Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) Apr, 2015 | Pubmed ID: 25732842
Understanding biomarkers of neurodegeneration: Ultrasensitive detection techniques pave the way for mechanistic understanding.
Nature medicine Mar, 2015 | Pubmed ID: 25742456
Monocyte and microglial activation in patients with mood-stabilized bipolar disorder.
Journal of psychiatry & neuroscience : JPN Jul, 2015 | Pubmed ID: 25768030
Neurological consequences of traumatic brain injuries in sports.
Molecular and cellular neurosciences May, 2015 | Pubmed ID: 25770439
First administration of the Fc-attenuated anti-β amyloid antibody GSK933776 to patients with mild Alzheimer's disease: a randomized, placebo-controlled study.
PloS one , 2015 | Pubmed ID: 25789616
A highly sensitive novel immunoassay specifically detects low levels of soluble Aβ oligomers in human cerebrospinal fluid.
Alzheimer's research & therapy , 2015 | Pubmed ID: 25802556
Insulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOEɛ4 Carriers.
Journal of Alzheimer's disease : JAD , 2015 | Pubmed ID: 25812851
Amyloid biomarkers in Alzheimer's disease.
Trends in pharmacological sciences May, 2015 | Pubmed ID: 25840462
Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients.
The Journal of clinical investigation May, 2015 | Pubmed ID: 25844897
Effect of Cognitive Reserve on Age-Related Changes in Cerebrospinal Fluid Biomarkers of Alzheimer Disease.
JAMA neurology Jun, 2015 | Pubmed ID: 25893879
APP metabolism regulates tau proteostasis in human cerebral cortex neurons.
Cell reports May, 2015 | Pubmed ID: 25921538
Cognitive performance and cerebrospinal fluid biomarkers of neurodegeneration: a study of patients with bipolar disorder and healthy controls.
PloS one , 2015 | Pubmed ID: 25954806
Serum visinin-like protein-1 in concussed professional ice hockey players.
Brain injury , 2015 | Pubmed ID: 25955117
First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression.
Brain : a journal of neurology Jul, 2015 | Pubmed ID: 25981962
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
JAMA May, 2015 | Pubmed ID: 25988462
Absence of Cerebrospinal Fluid Signs of Neuronal Injury Before and After Immediate Antiretroviral Therapy in Acute HIV Infection.
The Journal of infectious diseases Dec, 2015 | Pubmed ID: 25995196
Increased levels of inflammatory immune mediators in vitreous from pseudophakic eyes.
Investigative ophthalmology & visual science May, 2015 | Pubmed ID: 26024125
CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology Aug, 2015 | Pubmed ID: 26024928
Benchmarking biomarker-based criteria for Alzheimer's disease: Data from the Swedish Dementia Registry, SveDem.
Alzheimer's & dementia : the journal of the Alzheimer's Association Dec, 2015 | Pubmed ID: 26079415
C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association Dec, 2015 | Pubmed ID: 26092348
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study.
Neurobiology of aging Sep, 2015 | Pubmed ID: 26093515
The impact of Tween 20 on repeatability of amyloid β and tau measurements in cerebrospinal fluid.
Clinical chemistry and laboratory medicine Nov, 2015 | Pubmed ID: 26103629
Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia.
Brain : a journal of neurology Sep, 2015 | Pubmed ID: 26133663
Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls.
Alzheimer's research & therapy , 2015 | Pubmed ID: 26136856
Pre-analytical and analytical factors influencing Alzheimer's disease cerebrospinal fluid biomarker variability.
Clinica chimica acta; international journal of clinical chemistry Sep, 2015 | Pubmed ID: 26141614
Cerebrospinal fluid biomarkers for Alzheimer's disease: current limitations and recent developments.
Current opinion in psychiatry Sep, 2015 | Pubmed ID: 26147615
The Gothenburg MCI study: Design and distribution of Alzheimer's disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism Jan, 2016 | Pubmed ID: 26174331
The cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer's disease.
AIDS research and therapy , 2015 | Pubmed ID: 26175795
The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans.
Alzheimer's & dementia : the journal of the Alzheimer's Association Jul, 2015 | Pubmed ID: 26194312
Clearance systems in the brain-implications for Alzheimer disease.
Nature reviews. Neurology Aug, 2015 | Pubmed ID: 26195256
Round robin test on quantification of amyloid-β 1-42 in cerebrospinal fluid by mass spectrometry.
Alzheimer's & dementia : the journal of the Alzheimer's Association Jan, 2016 | Pubmed ID: 26206625
Alzheimer's disease--subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism Jan, 2016 | Pubmed ID: 26219595
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.
Brain : a journal of neurology Sep, 2015 | Pubmed ID: 26220940
Plasma amyloid β-quo vadis?
Neurobiology of aging Oct, 2015 | Pubmed ID: 26234755
The relationship between CSF tau markers, hippocampal volume and delayed primacy performance in cognitively intact elderly individuals.
Alzheimer's & dementia (Amsterdam, Netherlands) Mar, 2015 | Pubmed ID: 26258161
Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease.
JAMA neurology Oct, 2015 | Pubmed ID: 26258692
Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction.
PloS one , 2015 | Pubmed ID: 26317831
Impact of cerebrospinal fluid matrix on the detection of Alzheimer's disease with Aβ42 and influence of disease on the total-Aβ42/Aβ40 ratio.
Journal of neurochemistry Dec, 2015 | Pubmed ID: 26332787
Protective properties of lysozyme on β-amyloid pathology: implications for Alzheimer disease.
Neurobiology of disease Nov, 2015 | Pubmed ID: 26334479
Reduced cerebrospinal fluid concentrations of oxysterols in response to natalizumab treatment of relapsing remitting multiple sclerosis.
Journal of the neurological sciences Nov, 2015 | Pubmed ID: 26342940
A Practical Guide to Immunoassay Method Validation.
Frontiers in neurology , 2015 | Pubmed ID: 26347708
Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease.
Neurology Oct, 2015 | Pubmed ID: 26354982
Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study.
Alzheimer's & dementia : the journal of the Alzheimer's Association Feb, 2016 | Pubmed ID: 26368321
Neurogranin Levels in Cerebrospinal Fluid: A New Addition to the Alzheimer Disease Diagnostic Toolbox.
JAMA neurology Nov, 2015 | Pubmed ID: 26368650
Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
Brain : a journal of neurology Nov, 2015 | Pubmed ID: 26373605
Biomarkers in Sporadic and Familial Alzheimer's Disease.
Journal of Alzheimer's disease : JAD , 2015 | Pubmed ID: 26401553
Case Report of Complex Amyotrophic Lateral Sclerosis with Cognitive Impairment and Cortical Amyloid Deposition.
Journal of Alzheimer's disease : JAD , 2015 | Pubmed ID: 26401701
Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment.
Journal of Alzheimer's disease : JAD , 2015 | Pubmed ID: 26401704
Does Caffeine Consumption Modify Cerebrospinal Fluid Amyloid-β Levels in Patients with Alzheimer's Disease?
Journal of Alzheimer's disease : JAD , 2015 | Pubmed ID: 26401784
Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline.
Journal of Alzheimer's disease : JAD Sep, 2015 | Pubmed ID: 26402088
Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease.
Journal of Alzheimer's disease : JAD , 2015 | Pubmed ID: 26402100
Dissecting IWG-2 typical and atypical Alzheimer's disease: insights from cerebrospinal fluid analysis.
Journal of neurology Dec, 2015 | Pubmed ID: 26410752
Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease.
Journal of Alzheimer's disease : JAD , 2015 | Pubmed ID: 26444757
The Expression of Transthyretin and Amyloid-β Protein Precursor is Altered in the Brain of Idiopathic Normal Pressure Hydrocephalus Patients.
Journal of Alzheimer's disease : JAD , 2015 | Pubmed ID: 26444765
Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease.
Neuroscience letters Nov, 2015 | Pubmed ID: 26453765
The past and the future of Alzheimer's disease CSF biomarkers-a journey toward validated biochemical tests covering the whole spectrum of molecular events.
Frontiers in neuroscience , 2015 | Pubmed ID: 26483625
Cerebrospinal Fluid Fatty Acid-Binding Protein 3 is Related to Dementia Development in a Population-Based Sample of Older Adult Women Followed for 8 Years.
Journal of Alzheimer's disease : JAD , 2015 | Pubmed ID: 26484922
Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements.
Clinical chemistry and laboratory medicine Jul, 2016 | Pubmed ID: 26495928
Increased CSF biomarkers of angiogenesis in Parkinson disease.
Neurology Nov, 2015 | Pubmed ID: 26511451
Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression.
JAMA neurology Jan, 2016 | Pubmed ID: 26524180
The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases.
Frontiers in neurology , 2015 | Pubmed ID: 26528237
CACNA1C polymorphism and altered phosphorylation of tau in bipolar disorder.
The British journal of psychiatry : the journal of mental science Feb, 2016 | Pubmed ID: 26541689
Pro-inflammatory S100A9 Protein as a Robust Biomarker Differentiating Early Stages of Cognitive Impairment in Alzheimer's Disease.
ACS chemical neuroscience Jan, 2016 | Pubmed ID: 26550994
Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1-42) in human cerebrospinal fluid.
Alzheimer's & dementia : the journal of the Alzheimer's Association May, 2016 | Pubmed ID: 26555316
Serum IGF-1 is higher in patients with idiopathic normal pressure hydrocephalus than in the population.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society Dec, 2015 | Pubmed ID: 26572963
Apolipoprotein E ϵ4 is positively related to spatial performance but unrelated to hippocampal volume in healthy young adults.
Behavioural brain research Feb, 2016 | Pubmed ID: 26581118
Cardiorespiratory Fitness Attenuates the Influence of Amyloid on Cognition.
Journal of the International Neuropsychological Society : JINS Nov, 2015 | Pubmed ID: 26581795
Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay.
Molecular neurodegeneration , 2015 | Pubmed ID: 26627638
Neuromodulation of fast-spiking and non-fast-spiking hippocampal CA1 interneurons by human cerebrospinal fluid.
The Journal of physiology Feb, 2016 | Pubmed ID: 26634295
Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases.
Neurobiology of aging Feb, 2016 | Pubmed ID: 26643944
Total-tau and neurofilament light in CSF reflect spinal cord ischaemia after endovascular aortic repair.
Neurochemistry international Feb, 2016 | Pubmed ID: 26682901
Cerebrospinal fluid markers of central nervous system injury in decompression illness - a case-controlled pilot study.
Diving and hyperbaric medicine Dec, 2015 | Pubmed ID: 26687311
APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment.
Alzheimer's research & therapy , 2015 | Pubmed ID: 26689589
Intracranial Arterial 4D-Flow is Associated with Metrics of Brain Health and Alzheimer's Disease.
Alzheimer's & dementia (Amsterdam, Netherlands) Dec, 2015 | Pubmed ID: 26693176
Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer's disease.
Alzheimer's research & therapy , 2015 | Pubmed ID: 26698298
Serum Neurofilament Light in American Football Athletes over the Course of a Season.
Journal of neurotrauma Oct, 2016 | Pubmed ID: 26700106
Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry Sep, 2016 | Pubmed ID: 26746185
Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease.
Molecular neurodegeneration , 2016 | Pubmed ID: 26754172
Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone.
Multiple sclerosis (Houndmills, Basingstoke, England) Jan, 2016 | Pubmed ID: 26754805
Effect of Docosahexaenoic Acid on a Biomarker of Head Trauma in American Football.
Medicine and science in sports and exercise Jun, 2016 | Pubmed ID: 26765633
Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease.
Annals of clinical and translational neurology Jan, 2016 | Pubmed ID: 26783546
Single-Molecule Imaging of Individual Amyloid Protein Aggregates in Human Biofluids.
ACS chemical neuroscience Mar, 2016 | Pubmed ID: 26800462
Increased CSF neurogranin concentration is specific to Alzheimer disease.
Neurology Mar, 2016 | Pubmed ID: 26826204
Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes.
Alzheimer's & dementia (Amsterdam, Netherlands) Dec, 2015 | Pubmed ID: 26835507
Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease.
Journal of Alzheimer's disease : JAD , 2015 | Pubmed ID: 26836182
Cerebral white matter lesions - associations with Aβ isoforms and amyloid PET.
Scientific reports , 2016 | Pubmed ID: 26856756
Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study.
EBioMedicine Jan, 2016 | Pubmed ID: 26870824
Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease.
Movement disorders : official journal of the Movement Disorder Society Jun, 2016 | Pubmed ID: 26878815
Erratum to: Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay.
Molecular neurodegeneration , 2016 | Pubmed ID: 26907468
Serum erythropoietin and outcome after ischaemic stroke: a prospective study.
BMJ open , 2016 | Pubmed ID: 26916692
Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry.
Clinical proteomics , 2016 | Pubmed ID: 26924951
α-Synuclein in Neurodegeneration-A Good Protein that may go Bad.
Brain pathology (Zurich, Switzerland) May, 2016 | Pubmed ID: 26940253
sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers.
EMBO molecular medicine , 2016 | Pubmed ID: 26941262
YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis.
Journal of neuroimmunology Mar, 2016 | Pubmed ID: 26943959
Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis.
Nature communications , 2016 | Pubmed ID: 26948379
A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans.
Alzheimer's research & therapy , 2016 | Pubmed ID: 26948580
Orexin-A is Associated with Increases in Cerebrospinal Fluid Phosphorylated-Tau in Cognitively Normal Elderly Subjects.
Sleep , 2016 | Pubmed ID: 26951396
Cerebrospinal fluid ratios with Aβ42 predict preclinical brain β-amyloid accumulation.
Alzheimer's & dementia (Amsterdam, Netherlands) , 2016 | Pubmed ID: 26955655
Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics.
Journal of Alzheimer's disease : JAD Mar, 2016 | Pubmed ID: 26967210
The Vanderbilt Memory & Aging Project: Study Design and Baseline Cohort Overview.
Journal of Alzheimer's disease : JAD Mar, 2016 | Pubmed ID: 26967211
Identification of tissue-specific cell death using methylation patterns of circulating DNA.
Proceedings of the National Academy of Sciences of the United States of America Mar, 2016 | Pubmed ID: 26976580
Defeating Alzheimer's disease and other dementias: a priority for European science and society.
The Lancet. Neurology Apr, 2016 | Pubmed ID: 26987701
β-Amyloid precursor protein-b is essential for Mauthner cell development in the zebrafish in a Notch-dependent manner.
Developmental biology May, 2016 | Pubmed ID: 26994945
Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) Mar, 2016 | Pubmed ID: 27003946
Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges.
Alzheimer's & dementia (Amsterdam, Netherlands) , 2016 | Pubmed ID: 27019866
Clearance systems in the brain--implications for Alzheimer diseaser.
Nature reviews. Neurology Apr, 2016 | Pubmed ID: 27020556
C3 deficiency ameliorates the negative effects of irradiation of the young brain on hippocampal development and learning.
Oncotarget Apr, 2016 | Pubmed ID: 27029069
CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease.
Annals of clinical and translational neurology Mar, 2016 | Pubmed ID: 27042676
Plasma neurofilament light chain predicts progression in progressive supranuclear palsy.
Annals of clinical and translational neurology Mar, 2016 | Pubmed ID: 27042681
Putamen volume and its clinical and neurological correlates in primary HIV infection.
AIDS (London, England) Jul, 2016 | Pubmed ID: 27045376
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
The Lancet. Neurology Jun, 2016 | Pubmed ID: 27068280
Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa.
Clinical chemistry and laboratory medicine Oct, 2016 | Pubmed ID: 27071153
Insulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults.
Journal of Alzheimer's disease : JAD Apr, 2016 | Pubmed ID: 27079723
Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study.
BMC infectious diseases , 2016 | Pubmed ID: 27103116
Cerebrospinal fluid levels of insulin, leptin, and agouti-related protein in relation to BMI in pregnant women.
Obesity (Silver Spring, Md.) Jun, 2016 | Pubmed ID: 27130070
Monitoring of 30 marker candidates in early Parkinson disease as progression markers.
Neurology Jul, 2016 | Pubmed ID: 27164658
Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease.
Neurology May, 2016 | Pubmed ID: 27164711
CSF Aβ1-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisation.
Clinica chimica acta; international journal of clinical chemistry May, 2016 | Pubmed ID: 27216941
Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice?
Alzheimer's & dementia (Amsterdam, Netherlands) Sep, 2015 | Pubmed ID: 27239518
Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease: A prospective 9-year study.
Alzheimer's & dementia (Amsterdam, Netherlands) Dec, 2015 | Pubmed ID: 27239521
Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia.
Alzheimer's & dementia (Amsterdam, Netherlands) Dec, 2015 | Pubmed ID: 27239524
Plasma β-amyloid in Alzheimer's disease and vascular disease.
Scientific reports , 2016 | Pubmed ID: 27241045
Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment.
PloS one , 2016 | Pubmed ID: 27295036
Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia.
Movement disorders : official journal of the Movement Disorder Society Aug, 2016 | Pubmed ID: 27296778
Low Circulating Acute Brain-Derived Neurotrophic Factor Levels Are Associated With Poor Long-Term Functional Outcome After Ischemic Stroke.
Stroke; a journal of cerebral circulation Jul, 2016 | Pubmed ID: 27301948
APOE ε4 carriers may undergo synaptic damage conferring risk of Alzheimer's disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association Jun, 2016 | Pubmed ID: 27321472
Corrigendum to: "Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: A cross-sectional study" [EBioMedicine 3 (216) 135-140].
EBioMedicine May, 2016 | Pubmed ID: 27322482
Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife.
Brain : a journal of neurology Aug, 2016 | Pubmed ID: 27324877
Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington's disease.
Journal of neurochemistry Oct, 2016 | Pubmed ID: 27344050
Amyloid precursor protein expression and processing are differentially regulated during cortical neuron differentiation.
Scientific reports , 2016 | Pubmed ID: 27383650
Neurofilament Light: A Dynamic Cross-Disease Fluid Biomarker for Neurodegeneration.
Neuron Jul, 2016 | Pubmed ID: 27387643
Blood biomarkers indicate mild neuroaxonal injury and increased amyloid β production after transient hypoxia during breath-hold diving.
Brain injury , 2016 | Pubmed ID: 27389622
A Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer's Disease.
Journal of Alzheimer's disease : JAD Jul, 2016 | Pubmed ID: 27392867
Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals.
Journal of neurovirology Jul, 2016 | Pubmed ID: 27400930
Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study.
Brain : a journal of neurology Sep, 2016 | Pubmed ID: 27401520
Cerebrospinal fluid analysis for HIV replication and biomarkers of immune activation and neurodegeneration in long-term atazanavir/ritonavir monotherapy treated patients.
Medicine Jul, 2016 | Pubmed ID: 27428202
No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau (p-tau).
Virulence Jul, 2016 | Pubmed ID: 27435879
Association between Plasma Homocysteine Levels and Neuronal Injury in HIV Infection.
PloS one , 2016 | Pubmed ID: 27441551
The APOE Genotype in Idiopathic Normal Pressure Hydrocephalus.
PloS one , 2016 | Pubmed ID: 27441602
Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders.
Alzheimer's & dementia (Amsterdam, Netherlands) , 2016 | Pubmed ID: 27453931
Validation of a new assay for α-synuclein detection in cerebrospinal fluid.
Clinical chemistry and laboratory medicine Jul, 2016 | Pubmed ID: 27474841
Increased Cerebrospinal Fluid Levels of Ubiquitin Carboxyl-Terminal Hydrolase L1 in Patients with Alzheimer's Disease.
Dementia and geriatric cognitive disorders extra May-Aug, 2016 | Pubmed ID: 27504117
State-dependent alterations in cerebrospinal fluid Aβ42 levels in cognitively intact elderly with late-life major depression.
Neuroreport Sep, 2016 | Pubmed ID: 27508979
Increased neurogranin concentrations in cerebrospinal fluid of Alzheimer's disease and in mild cognitive impairment due to AD.
Journal of neural transmission (Vienna, Austria : 1996) Aug, 2016 | Pubmed ID: 27531278
Calcium supplementation and risk of dementia in women with cerebrovascular disease.
Neurology Aug, 2016 | Pubmed ID: 27534711
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.
EMBO molecular medicine Oct, 2016 | Pubmed ID: 27534871
Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS.
Neurology® neuroimmunology & neuroinflammation Oct, 2016 | Pubmed ID: 27536708
Serum neurofilament light protein as a marker for diffuse axonal injury - results from a case series study.
Journal of neurotrauma Aug, 2016 | Pubmed ID: 27539721
Beneficial effects of increased lysozyme levels in Alzheimer's disease modelled in Drosophila melanogaster.
The FEBS journal Oct, 2016 | Pubmed ID: 27562772
Diagnosing Dementia in the Clinical Setting: Can Amyloid PET Provide Additional Value Over Cerebrospinal Fluid?
Journal of Alzheimer's disease : JAD Aug, 2016 | Pubmed ID: 27567830
Reduced Slow-Wave Sleep Is Associated with High Cerebrospinal Fluid Aβ42 Levels in Cognitively Normal Elderly.
Sleep Aug, 2016 | Pubmed ID: 27568802
Reference measurement procedure for CSF amyloid beta (Aβ)1-42 and the CSF Aβ1-42 /Aβ1-40 ratio - a cross-validation study against amyloid PET.
Journal of neurochemistry Aug, 2016 | Pubmed ID: 27579672
Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia.
Neurology Sep, 2016 | Pubmed ID: 27581216
Specific Triazine Herbicides Induce Amyloid-β42 Production.
Journal of Alzheimer's disease : JAD Sep, 2016 | Pubmed ID: 27589520
Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer's Disease.
Journal of Alzheimer's disease : JAD Sep, 2016 | Pubmed ID: 27589532
CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease.
Proteomics. Clinical applications Sep, 2016 | Pubmed ID: 27604409
No diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF.
Molecular neurodegeneration , 2016 | Pubmed ID: 27605218
Fluid biomarkers for mild traumatic brain injury and related conditions.
Nature reviews. Neurology Oct, 2016 | Pubmed ID: 27632903
Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker Candidates.
Journal of Alzheimer's disease : JAD Sep, 2016 | Pubmed ID: 27636850
The ACE Gene Is Associated with Late-Life Major Depression and Age at Dementia Onset in a Population-Based Cohort.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry Jun, 2016 | Pubmed ID: 27639288
Cerebrospinal fluid viral load and biomarkers of neuronal and glial cells in Ramsay Hunt syndrome.
The European journal of neuroscience Sep, 2016 | Pubmed ID: 27643680
Cerebrospinal Fluid Amyloid Beta and Tau Concentrations Are Not Modulated by 16 Weeks of Moderate- to High-Intensity Physical Exercise in Patients with Alzheimer Disease.
Dementia and geriatric cognitive disorders Sep, 2016 | Pubmed ID: 27643858
Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer's Disease and Other Neurodegenerative Disorders.
Neuromolecular medicine Sep, 2016 | Pubmed ID: 27646979
Neurochemical Aftermath of Repetitive Mild Traumatic Brain Injury.
JAMA neurology Sep, 2016 | Pubmed ID: 27654934
Cerebrospinal Fluid Inflammatory Biomarkers Reflect Clinical Severity in Huntington's Disease.
PloS one , 2016 | Pubmed ID: 27657730
Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-β Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease.
Journal of Alzheimer's disease : JAD Sep, 2016 | Pubmed ID: 27662287
Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization.
Journal of Alzheimer's disease : JAD Sep, 2016 | Pubmed ID: 27662295
Preclinical Amyloid-β and Axonal Degeneration Pathology in Delirium.
Journal of Alzheimer's disease : JAD Sep, 2016 | Pubmed ID: 27662296
Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies.
Neurobiology of aging Sep, 2016 | Pubmed ID: 27666590
Asymptomatic Cerebrospinal Fluid HIV-1 Viral Blips and Viral Escape During Antiretroviral Therapy: a Longitudinal Study.
The Journal of infectious diseases Sep, 2016 | Pubmed ID: 27683820
Multicenter immunoassay validation of cerebrospinal fluid neurofilament light: a biomarker for neurodegeneration.
Bioanalysis Nov, 2016 | Pubmed ID: 27684648
Plasma concentrations of free amyloid-β cannot predict the development of Alzheimer's disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association Sep, 2016 | Pubmed ID: 27693182
A common challenge in older adults: Classification, overlap, and therapy of depression and dementia.
Alzheimer's & dementia : the journal of the Alzheimer's Association Sep, 2016 | Pubmed ID: 27693188
Plasma tau in Alzheimer disease.
Neurology Sep, 2016 | Pubmed ID: 27694257
The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease.
Alzheimer's research & therapy Oct, 2016 | Pubmed ID: 27716408
Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis.
Journal of neuroimmunology Oct, 2016 | Pubmed ID: 27725108
Blood Biomarkers for Alzheimer's Disease: Much Promise, Cautious Progress.
Molecular diagnosis & therapy Feb, 2017 | Pubmed ID: 27738910
CSF neurofilament light levels predict hippocampal atrophy in cognitively healthy older adults.
Neurobiology of aging Jan, 2017 | Pubmed ID: 27794264
Serum neurofilament light protein predicts clinical outcome in traumatic brain injury.
Scientific reports Nov, 2016 | Pubmed ID: 27819296
Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease.
Scientific reports Dec, 2016 | Pubmed ID: 27929120
Expanding the cerebrospinal fluid endopeptidome.
Proteomics Mar, 2017 | Pubmed ID: 28044435
Genome-wide association study identifies MAPT locus influencing human plasma tau levels.
Neurology Feb, 2017 | Pubmed ID: 28100725
Neurofilament Protein and Antineurofilament Antibodies Following Traumatic Brain Injury-Reply.
JAMA neurology Mar, 2017 | Pubmed ID: 28135356
Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.
Neurology Mar, 2017 | Pubmed ID: 28179466
Ex vivo (18)O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway.
Molecular neurodegeneration Feb, 2017 | Pubmed ID: 28219449
The immune response of the human brain to abdominal surgery.
Annals of neurology Mar, 2017 | Pubmed ID: 28253549
Astroglial activation and altered amyloid metabolism in human repetitive concussion.
Neurology Mar, 2017 | Pubmed ID: 28283595
Microstructural white matter alterations in preclinical Alzheimer's disease detected using free water elimination diffusion tensor imaging.
PloS one , 2017 | Pubmed ID: 28291839
Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports.
Neurology May, 2017 | Pubmed ID: 28404801
Applying fluid biomarkers to Alzheimer's disease.
American journal of physiology. Cell physiology Jul, 2017 | Pubmed ID: 28424166
Inflammation, Amyloid, and Atrophy in The Aging Brain: Relationships with Longitudinal Changes in Cognition.
Journal of Alzheimer's disease : JAD , 2017 | Pubmed ID: 28505968
A Season of American Football Is Not Associated with Changes in Plasma Tau.
Journal of neurotrauma Aug, 2017 | Pubmed ID: 28614998
Increased levels of ascorbic acid in the cerebrospinal fluid of cognitively intact elderly patients with major depression: a preliminary study.
Scientific reports Jun, 2017 | Pubmed ID: 28615661
Neuroinflammation and Tau Interact with Amyloid in Predicting Sleep Problems in Aging Independently of Atrophy.
Cerebral cortex (New York, N.Y. : 1991) Jun, 2017 | Pubmed ID: 28655157
Cerebrospinal fluid monoamine metabolite profiles in bipolar disorder, ADHD, and controls.
Journal of neural transmission (Vienna, Austria : 1996) Jun, 2017 | Pubmed ID: 28656371
Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.
Journal of Alzheimer's disease : JAD , 2017 | Pubmed ID: 28697566
Intracranial Arterial 4D Flow in Individuals with Mild Cognitive Impairment is Associated with Cognitive Performance and Amyloid Positivity.
Journal of Alzheimer's disease : JAD , 2017 | Pubmed ID: 28826187
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders.
Proteomics. Clinical applications Oct, 2017 | Pubmed ID: 28972305
Serum tau and neurological outcome in cardiac arrest.
Annals of neurology Nov, 2017 | Pubmed ID: 28981963
A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease.
Proteomics. Clinical applications Oct, 2017 | Pubmed ID: 29028155
Structural brain abnormalities in successfully treated HIV infection: associations with disease and cerebrospinal fluid biomarkers.
The Journal of infectious diseases Oct, 2017 | Pubmed ID: 29069436
Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington's disease R6/2 mice.
Scientific reports Oct, 2017 | Pubmed ID: 29074982
Low-dose γ-secretase inhibition increases secretion of Aβ peptides and intracellular oligomeric Aβ.
Molecular and cellular neurosciences Dec, 2017 | Pubmed ID: 29104140
Obstructive Sleep Apnea Severity Affects Amyloid Burden in Cognitively Normal Elderly: A Longitudinal Study.
American journal of respiratory and critical care medicine Nov, 2017 | Pubmed ID: 29125327
Central and Peripheral Leptin and Agouti-Related Protein during and after Pregnancy in Relation to Weight Change.
Clinical endocrinology Nov, 2017 | Pubmed ID: 29154467
Wendy E. Heywood*,1,
Anna Baud*,1,
Emily Bliss1,
Ernestas Sirka1,
Jonathan M. Schott2,
Henrik Zetterberg3,
Daniela Galimberti4,
Neil J. Sebire5,
Kevin Mills1
1Centre for Translational Omics, Genetics and Genomic Medicine Deptartment, Great Ormond Street Institute of Child Health, University College London,
2Dementia Research Centre, Institute of Neurology, University College London,
3Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg,
4Neurology Unit, Department of Pathophysiology and Transplantation, University of Milan,
5Great Ormond Street Hospital for Children, University College London
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유